Women's health and the metabolic syndrome

Annals of the New York Academy of Sciences

Volumn 1092, Issue , 2006, Pages 33-48

  Mitrakou, Asimina ^a  

^a HENRY DUNANT HOSPITAL   (Greece)

Author keywords

Cardiovascular disease (CVD); Dyslipidemia; Hypertension; Metabolic syndrome; Obesity

Indexed keywords

ESTROGEN;

ABDOMINAL OBESITY; AGE; ATHEROSCLEROSIS; BEHAVIOR MODIFICATION; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DYSLIPIDEMIA; ENDOCRINE DISEASE; EXERCISE; HEREDITY; HUMAN; HYPERTENSION; IMMOBILIZATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; WEIGHT REDUCTION; WOMEN'S HEALTH; FEMALE; REVIEW;

FEMALE; HUMANS; METABOLIC SYNDROME X; WOMEN'S HEALTH;

EID: 34247202026     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1365.003     Document Type: Conference Paper

References (85)

1. ECKEL, R.H., S.M. BRUNDY & P.Z. ZIMMET. 2005. The metabolic syndrome. Lancet 365: 1415-1428.
2. ALEXANDER, C.M., P.B. LANDSMAN, S.M. TEUTSCH & S.M. HAFFNER. 2003. Third National Health and Nutrition Examination Survey (NHANES III)I; National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52: 1210-1214.
3. REAVEN, G.M. 1988. Banting Lecture 1988 Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
4. INTERNATIONAL DIABETES FEDERATION. The IDF consensus worldwide definition of the metabolic syndrome. Available at: htpp://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf.
5. FERRANNINI, E., S. VICHI, H. BECK- NIELSEN, et al. 1996. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 45: 947-953.
6. ALBERTI, K.G. & P.Z. ZIMMET. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15: 539-553.
7. BALKAU, B. & M.A. CHARLES. 1999. Comment on the provisional report from the WHO consultation European Group for the Study of Insulin Resistance (EGIR). Diabet. Med. 16: 442-443.
8. BALKAU, B., M.A. CHARLES, T. DRIVSSHOLM, et al. 2002. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 28: 364-376.
9. EXECUTIVE SUMMARY OF THE THIRD REPORT OF THE NATIONAL CHOLESTEROL EDUCATION PROGRAM (NCEP) EXPERT PANEL ON DETECTION, EVALUATION AND TREATMENT OF HIGH BLOOD CHOLESTEROL IN ADULTS (ADULT TREATMENT PANEL III). 2001. JAMA 285: 2486-2497.
10. FORD, E.S., W.H. GILES & W.H. DIETZ. 2002. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 287: 356-359.
11. FORD, E.S., W.H. GILES & A.H. MOKDAD. 2004. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27: 2444-2449.
12. HEDLEY, A.A., C.L. JOHNSON, M.D. CARROLL, et al. 2004. Prevalence of overweight and obesity among US children, adolescents and adults 1999-2002. JAMA 291: 2847-2850.
13. MOKDAD, A.H., E.S. FORD, B.A. BOWMAN, et al. 2003. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289: 76-79.
14. DALLONGEVILLE, J., D. COTTEL, D. ARVEILLER, et al. 2004. The association of the metabolic disorders with the metabolic syndrome is different in men and women. Ann. Nutr. Metab. 48: 43-50.
15. WAJCHENBERG, B.L. 2000. Subcutaneous and visceral adipose tissue their relation to the metabolic syndrome. Endocr. Rev. 21: 697-738.
16. HILLS, S., B. BALKAU, S. COPPACK, et al. 2004. The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodol. Object. Diabetol. 47: 566-570.
17. PANAGIOTAKOS, D., C. PITSAVOS, C. CHRYSOHOOU, et al. 2004. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the Attica Study. Am. Heart J. 147: 106-112.
18. LAUENBORG, J., E. MATHIESEN, T. HANSEN, et al. 2005. The prevalence of the metabolic syndrome in a Danish Population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J. Clin. Endocr. Metab. 90: 4004-4010.
19. GRUNDY, S., H. BREWER, H.B. CLEEMAN, JR., et al. 2004. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 105: 433-438.
20. LIVINGSTON, E.H. 2006. Lower body subcutaneous fat accumulation and diabetes mellitus risk. Surg. Obes. Relat. Dis. 2: 362-368.
21. ENZI, G., M. GASPARO, P.R. BIONDETTI, et al. 1986. Subcutaneous and visceral fat distribution according to sex, age, and overweight evaluated by computed tomography. Am. J. Clin. Nutr. 44: 739-746.
22. MATSUZAUA, Y., T. NAKAMURA, I. SHIMOMURA, et al. 1996. Visceral fat accumulation and cardiovascular disease. In Progress in Obesity Research Proceedings of the Seventh International Congress on Obesity (Toronto, Canada, August 20-25, 1994). A. Angel, H. Anderson, C. Bouchard, D. Lau, L. Leitter, R. Mendelson, Eds.: 569-572. John Libbey and Company. London.
23. NIELSEN, S., Z. GUO, C.M. JOHNSON, et al. 2004. Splachnic lipolysis in humans. J. Clin. Invest. 113: 1582-1588.
24. MAYES, J.S. & G.H. WATSON. 2004. Direct effect of sex steroid hormones on adipose tissues and obesity. Obes. Rev. 5: 197-216.
25. LONNQVIST, F., A. THORNE, V. LARGE & P. ARNER. 1997. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler. Thromb. Vac. Biol. 17: 1472-1480.
26. PEDERSEN, S.B., K. KRISTENSEN, P.A. HERMANN, et al. 2004. Estrogen controls lipolysis by up regulating alpha 2 adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J. Clin. Endocrinol. Metab. 89: 1869-1876.
27. BODEN, G. & G.I. SHULMAN. 2002. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta cell dysfunction. Diabetes Care 25: 1135-1141.
28. BJONTROP, P. 2000. Metabolic difference between visceral fat and subcutaneous abdominal fat. Diabetes Metab. 26(Suppl. 3): 10-12.
29. RONTI, T., G. LUPATELLI & E. MANNARINO. 2006. The Endocrine function of adipose tissue: an update. Clin. Endocrinol. 64: 355-365.
30. CARO, J.F., M.K. SINHA & J.W. KOLACZYNSKI, et al. 1996. Leptin: the tale of an obesity gene. Diabetes 45: 1455-1462.
31. SIERRA-HONIGMANN, M.R., A.K. NATH & C. MURAKAMI, et al. 1998. Biological action of leptin as an angiogenic factor. Science 281: 1683-1686.
32. WALLACE, A.M., A.D. MCMAHON, C.J. PACKARD, et al.2001. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 104: 3052-3056.
33. MONTAGUE, C.T., J.B. PRINS, L. SANDERS, et al. 1997. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 46: 342-347.
34. KROTKIEWSKI, M., P. BJONTROP, I. SJOSTROM & U. SMITH. 1983. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J. Clin. Invest. 72: 1150-1162.
35. VAN HARMELEN, V., S. REYNISDOTTIR, P. ERIKSSON, et al. 1998. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47: 913-917.
36. COSTACOU, T., J.C. ZGIBOR & R.W. EVANS, et al. 2005. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes.The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 48: 41-48.
37. YANNAKOULIA, M., N. YIANNAKOURIS, S. BLUHER, et al. 2003. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J. Endocrinol. Metab. 85: 61-69.
38. RIDKER, F.M. & D.A. MORROW. 2003. C-reactive protein, inflammation and coronary risk. Cardiol. Clin. 21: 315-325.
39. RIDKER, PM., N. RIFAI, L. ROSE, et al. 2002. Comparison of C-reactive protein and low density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med 347: 1557-1565.
40. RIDKER, P.M., J.E. BURING, N.R. COOK & N. RIFAI. 2003. C-reactive protein, the metabolic syndrome and risk of incident cardiovascular events: an 8-year followup of 14719 initially healthy American women. Circulation 107: 391-397.
41. RUTTER, M.K., J.B. MEIGS, L.M. SULLIVAN, et al. 2004. C-reactive protein, the metabolic syndrome and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110: 380-385.
42. GOHLKE-BARWOLF, C. 2000. Coronary artery disease is menopause a risk factor. Basic Res. Cardiol. 95(Suppl 1): 171-183.
43. NICKENING, G. 2004. Should angiotensin II receptor blockers be combined? Circulation 110: 1013-1020.
44. PESCHERE-BERTSCHI, A. & M. BURNIER. 2004. Female sex hormones, salt and blood pressure regulation. Am. J. Hypertens. 17: 994-1001.
45. CHEURFA, N., A.F. REIS, D. DUBOIS LAFORGUE, et al. 2004. The Gly482Ser polymorphism in the peroxisome proliferator-activated receptor-gamma coactivator-1 gene is associated with hypertension in type 2 diabetic men. Diabetologia 47: 1980-1983.
46. HAFFNER, S.M., R.A. VALDEZ, H.P. HAZUDA, et al. 1992. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 41: 715-722.
47. LAASKO, M. 1993. How good a marker is insulin level for insulin resistance? Am. J. Epidemiol. 137: 959-965.
48. YKI-JARVINEN, H. 1984. Sex and insulin sensitivity. Metabolism 33: 1011-1015.
49. NUUTILA, P., J. KNUUTI, M. MAKI, et al. 1995. Gender and insulin sensitivity in the heart and in skeletal muscle: studies using positron emission tomography. Diabetes 44: 31-36.
50. FERRANNINI, E., A. NATALI, P. BELL, et al. 1997. Insulin resistance and hypersecretion in obesity. J. Clin. Invest. 100: 1166-1173.
51. ZAMBONI, M., F. ARMELLINI & M.P. MILANI. 1992. Body fat distribution in preand post-menopausal women: metabolic and anthropometric variables and their inter-relationships. Int. J. Obes. Relat. Metab. Disord. 16: 495-504.
52. BONORA, E., S. DEL PRATO, G. BONADONNA, et al. 1992. Total fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 41: 1151-1159.
53. FERRANNINI, E. & B. BALKAU. 2002. Insulin: in search of a syndrome. Diabetic Med. 19: 724-729.
54. WILLIAMS, C.M. 2004. Lipid metabolism in women. Proc. Nutr. Soc. 63: 153-160.
55. CENTERS FOR DISEASE CONTROL AND PREVENTION. 2005. Available at: www.cdc.gov/nccdphp/burdenbook2004/ index.htm.
56. MAJOR CARDIOVASCULAR DISEASE (CVD) DURING 1979-1999 AND MAJOR CVD HOSPITAL DISCHARGE RATES IN 1997 AMONG WOMEN WITH DIABETES -UNITED STATES. Available at www.cdc.gov/mmwr/preview/mmwrhtml/mm5043a2.htm.
57. AMERICAN HEART ASSOCIATION. Heart disease and stroke statistics-2005 update. Available at http//www.americanheart.org.
58. LERNER, D.J. & W.B. KANNEL. 1986. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow up of the Framingham population. Am. Heart J. 111: 383-390.
59. FRIEDMAN, D.S., J.D. OTVOS, F.J. JEYARAJAH, et al. 2004. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: The Framingham Study. Clin. Chem. 50: 1189-1200.
60. CUI, Y., R.S. BLUMENTHAL, J.A. FLAWS, et al. 2001. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch. Intern. Med. 161: 1413-1419.
61. HOKANSON, J.E. & M.A. AUSTIN. 1996. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein level: a meta analysis of population-based prospective studies. J. Cardiovasc. Risk 3: 213-219.
62. ISOMAA, B., P. ALMGREN, T. TUOMI, et al. 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683-689.
63. POPE, J.H., T.P. AUFDERHEIDE, R. RUTHAZER, et al. 2003. Missed diagnosis of acute cardiac ischemia in the emergency department. N. Engl. J. Med. 342: 1163-1170.
64. BAIREY MERZ, C.N., S.F. KELSEY, C.J. PEPINE, et al. 1999. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design methodology and feasibility report. J. Am. Cardiol. 33: 1453-1461.
65. PEPINE, C.J., R.S. BALABAN, R.O. BONOW, et al. 2004. Women's Ischemic Syndrome Evaluation: current status and future research directions. Report of the National Heart, Lung, and Blood Institute Workshop: October 2-4, 2002. Section 1: Diagnosis of stable ischemia and ischemic heart disease. Circulation 109: 44e-46e.
66. SHAW, L., C.N. BAIREY METZ, C.J. PEPINE, et al. 2006. Insights from the NHLBIS-ponsored Women's Ischemia Syndrome Evaluation (WISE) Study Part = 1: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J. Am. Coll. Cardiol. 47(Suppl S): 4S-20S.
67. PANZA, M., A. JULIE, R. LAURIENZO, et al. 1997. Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography. J. Am. Coll. Cardiol. 29: 293-301.
68. CHEN, Q., S.E. REIS, C.M. KAMMERER, et al. 2003. APOE polymorphism and angiographic coronary artery disease severity in the Women's Ischemia Syndrome Evaluation (WISE) study. Atherosclerosis 169: 159-167.
69. WONG, N.D., M.G. SCIAMMARELLA, D. POLK, et al. 2003. The metabolic syndrome, diabetes and subclinical atherosclerosis assessed by coronary calcium. J. Am. Coll. Cardiol. 41: 1547-1553.
70. KIP, K.E., O.C. MARROQUIN & D.E. KELLEY. 2004. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women : a report from the Women's Ischemia Syndrome Evaluation (WISE). Circulation 109: 706-713.
71. MAROQUIN, O.C., K.E. KIP, D. KELLEY, et al. 2004. The metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary heart disease in women: a report from WISE. Circulation 1009: 714-721.
72. POELHAM, E.T. 2002. Menopause, energy expenditure and body composition. Acta Obstet. Gynecol. Scand. 3: 603-611.
73. RUTTER, M.K., B. MEIGS, L. SULLIVAN, et al. 2005. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 54: 3252-3257.
74. KAHN, R., J. BUSE, E. FERRANNINI & M. STERN. 2005. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28: 2289-2304.
75. SMITH, S.R. & J.J. ZACHWIEJA. Visceral adipose tissue: a critical review of intervention strategies. Int. J. Obes. 23: 329-335.
76. VISSER, M., L.M. BOUTER, G.M. MCQ UILLAN, et al. 1999. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282: 2131-2135.
77. ZICCARDI, P., F. NAPPO, G. GIUGLIANO, et al. 2002. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105: 804-809.
78. AMERICAN HEART ASSOCIATION. Heart disease and stroke statistics - 2005 update. Available at http//www.americanheart.org.
79. KIMM, S., W. GLYNN & A. KRISKA. 2002. Decline in physical activity in black girls and white girls during adolescence. N. Engl. J. Med. 347: 709-715.
80. PATE, R.R., M. PRATT, S.N. BLAIR, et al. 1995. Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 273: 402-407.
81. HIGGINS, M., W. KANNEL, R. GARRISON, et al. 1988. Hazards of obesity - the Framingham experience. Acta Med. Scand. 723(Suppl): 23-36.
82. MANSON, J., P. GREENLAND, A. LACROIX, et al. 2002.Walking compared to vigorous exercise for the prevention of cardiovascular events in women. N. Engl. J. Med. 347: 716-725.
83. BALKAU, B., E. VIERRON, M. VERNAY, et al. 2006. D.E.S.I.R Study Group. The impact of 3-year changes in lifestyle habits on metabolic syndrome parameters: the D.E.S.I.R study. Eur. J. Cardiovasc. Prev. Rehabil. 13: 334-340.
84. TUOMILEHTO, J., J. LINDSTROM, J. ERRIKSON, et al. 2001. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. N. Eng. J. Med. 344: 1343-1350.
85. DPP RESEARCH GROUP. 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346: 393-403.